As it stated in reliefweb
MSF reaction to GlaxoSmithKline's announcement on the reduction of pneumonia vaccine prices for humanitarian organisations - World
MSF reaction to GlaxoSmithKline's announcement on the reduction of pneumonia vaccine prices for humanitarian organisations - World
Reaction from Vickie Hawkins, Executive Director of MSF UKLondon, 19 September 2016 - "After years of fighting for children caught in crisis that are suffering from pneumonia and desperately need the vaccine, MSF is relieved to see that GlaxoSmithKline (GSK) finally plans to reduce their price for humanitarian organisations.GSK is leading the way in this commitment to children who are experiencing the most horrific of circumstances, while Pfizer continues to hide behind excuses and offer only piecemeal approaches to the humanitarian community," according to Vickie Hawkins, Executive Director of MSF UK."GSK has taken a positive and critical step forward for children in emergencies but our experience tells us that lack of access to life-saving vaccines it is not only specific to crisis contexts but also to the many developing countries who can't afford the vaccine.
by the same token on thepharmaletter
GSK to supply pneumonia vaccine to refugees at lowest price
GSK to supply pneumonia vaccine to refugees at lowest price
UK pharma major GlaxoSmithKline has announced it will supply its pneumococcal vaccine, Synflorix, to…In order to access this content you need to be logged into the site and have an active subscription or trial subscription.Please login, take a free trial or subscribe in order to continue reading.A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.
by the same token on msf
MSF welcomes GSK's decision to lower the price of the pneumonia vaccine
MSF welcomes GSK's decision to lower the price of the pneumonia vaccine
Médecins Sans Frontières/Doctors Without Borders/ (MSF) welcomes the decision by GlaxoSmithKline (GSK) to lower the price of its pneumococcal conjugate vaccine (PCV) for humanitarian organisations that serve refugee and crisis-affected children.For seven years, MSF has been in discussions with GSK and Pfizer – the only two manufacturers producing the pneumonia vaccine – for access to a more affordable price.GSK's price reduction is a significant step forward in protecting vulnerable children who are reached by humanitarian organisations like MSF.
No comments:
Post a Comment